Algernon Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 26 Apr 24 | BuyCA$4,940 | Christopher Moreau | Individual | 38,000 | CA$0.13 | |
| 29 Dec 23 | BuyCA$4,500 | Christopher Moreau | Individual | 60,000 | CA$0.075 | |
| 28 Dec 23 | BuyCA$4,650 | Christopher Moreau | Individual | 60,000 | CA$0.077 | |
| 27 Dec 23 | BuyCA$40,005 | Christopher Moreau | Individual | 533,400 | CA$0.075 | |
| 27 Dec 23 | BuyCA$21,000 | James Kinley | Individual | 280,000 | CA$0.075 |
Insider Trading Volume
Insider Buying: AGN insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 48,000 | 0.222% |
| Individual Insiders | 2,566,566 | 11.9% |
| Hedge Funds | 3,002,880 | 13.9% |
| General Public | 15,972,042 | 74% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 123.3%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 3,002,880 | CA$345.3k | 0% | 8.08% | |||
| 1,039,502 | CA$119.5k | 36.5% | no data | |||
| 810,992 | CA$93.3k | 179% | no data | |||
| 383,332 | CA$44.1k | 475% | no data | |||
| 173,180 | CA$19.9k | 705% | no data | |||
| 114,760 | CA$13.2k | 0% | no data | |||
| 48,000 | CA$5.5k | 0% | 100.0% | |||
| 44,800 | CA$5.2k | 147% | no data |